Approximately 1 million Aetna members will need new coverage with the announcement that CVS will be leaving the Affordable Care Act (ACA) individual exchange business next year.
CVS announced today that it would be withdrawing from the Affordable Care Act (ACA) individual exchange business in 2026, which would leave 1 million people in 17 states in the US without health insurance come next year.1,2
This is not an unprecedented move for the company, according to the Wall Street Journal. Aetna had first withdrawn from the ACA in 2017 and 2018 before its return in 2021. For this iteration of the withdrawal, the loss of money surrounding the provision of Aetna and the company’s claim to focus the portfolio of the company as it turns to a new deal with Novo Nordisk to sell semaglutide for weight loss (Wegovy) for a cash price.
The move also aligns with the scheduled end of tax credits for ACA premiums that were implemented during the Biden administration and are less likely to be extended with a Republican majority in the House. Temporary subsidies were also passed in 2021 under the Biden administration and extended in 2022 to provide financial help to those who needed assistance as they enrolled in the ACA. With both of these set to expire next year, individuals who bought coverage through the ACA may face increased premiums. This led to 23.6 million individuals enrolling in the ACA just this past year, a record high for enrollment.3
Individuals receiving Aetna coverage through the ACA will need to apply for different insurance this fall | Image credit: Annap - stock.adobe.com
Aetna health insurance is only a small amount of the total medical membership that CVS reported in 2025, according to Forbes,1 and Aetna is not a major player in the ACA compared with some other health insurance options. However, the next enrollment period in fall of 2025 will require that all individuals enrolled in Aetna purchase other types of health insurance as benefits are unveiled.1 This could leave individuals with less coverage or different coverage than they are used to or that they require.
The 1 million individuals are also spread throughout 17 states, which could impact the health systems across all the states as people may be required to change providers under new coverage. With other cuts to the ACA carried out by the Trump administration, including funding for patient navigators,4 the compounding effect could leave many in the dark when it comes to picking new insurance.
“The company is best able to serve members through its other health benefit solutions, which offer access to quality care, affordable health benefits and exceptional service. The company will continue delivering superior service and support to its individual exchange members through 2025 and residual activities in 2026,” CVS said in a statement reporting on its first quarter results from 2025.5
CVS also announced that it would be selling Wegovy in its retail stores at a discounted cash price with a new deal struck with Novo Nordisk, which would allow for individuals to pay $499 per month to receive the drug and pay for it out of pocket.2 This deal was made in an effort to increase accessibility to Wegovy as compounding pharmacies lose access to the drug.
References
Long-Term Lebrikizumab Provides Sustained Skin Clearance in Atopic Dermatitis
August 5th 2025In this subanalysis of data from the ADjoin trial of lebrikizumab, the interleukin-13 receptor inhibitor that is also a monoclonal antibody showed itself to be effective over the long term in patients with atopic dermatitis on maintenance therapy.
Read More
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More